Literature DB >> 2145683

The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro.

A J Pope1, J R Masters, A J MacRobert.   

Abstract

The photodynamic effect of a pulsed flashlamp pumped dye laser on cultured human bladder carcinoma cells was studied. MGH-U1 cells were incubated for 1 h in dihaematoporphyrin either (DHE) and then exposed to green laser light (504 nm, 20 Hz) for varying laser power densities (50-100 mW/cm2 and exposure times (2-15 s), representing incident pulse energy fluences of 2.5-5 mJ/cm2 and energy densities of 0.1-1.5 J/cm2. The cell survival was measured by clonogenic assay and controls exposed to either laser light alone or DHE in the dark showed no cytotoxicity. Sensitised cells were killed by energy densities of less than 1 J/cm2 (LD90 = 0.54 J/cm2). This demonstrates the probable effectiveness of a pulsed dye laser for photodynamic therapy provided that pulse fluence are below the saturation threshold of the photosensitiser (10 mJ/cm2).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145683     DOI: 10.1007/bf00294771

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  19 in total

1.  Clinical laser photodynamic therapy in the treatment of bladder carcinoma.

Authors:  B P Shumaker; F W Hetzel
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

2.  Detection of haematoporphyrin derivative and haematoporphyrin excited states in cell environments.

Authors:  T G Truscott; A J McLean; A M Phillips; W S Foulds
Journal:  Cancer Lett       Date:  1988-07       Impact factor: 8.679

3.  Comparison of the efficacy of pulsed and continuous-wave red laser light in induction of photocytotoxicity by haematoporphyrin derivative.

Authors:  P A Cowled; J R Grace; I J Forbes
Journal:  Photochem Photobiol       Date:  1984-01       Impact factor: 3.421

4.  Expression of potentially lethal damage in Chinese hamster cells exposed to hematoporphyrin derivative photodynamic therapy.

Authors:  C J Gomer; N Rucker; A Ferrario; A L Murphree
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

5.  Photodynamic therapy in the management of resistant lower urinary tract carcinoma.

Authors:  U O Nseyo; T J Dougherty; L Sullivan
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

6.  Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.

Authors:  U O Nseyo; T J Dougherty; D G Boyle; W R Potter; R Wolf; R Huben; J E Pontes
Journal:  Urology       Date:  1985-09       Impact factor: 2.649

7.  Photosensitization and split-dose recovery in cultured human urinary bladder carcinoma cells containing nonexchangeable hematoporphyrin derivative.

Authors:  D A Bellnier; C W Lin
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

8.  Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder.

Authors:  G R Prout; C W Lin; R Benson; U O Nseyo; J J Daly; P P Griffin; J Kinsey; M E Tian; Y H Lao; Y Z Mian
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

9.  Complications of whole bladder dihematoporphyrin ether photodynamic therapy.

Authors:  J I Harty; M Amin; T J Wieman; M T Tseng; D Ackerman; W Broghamer
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

10.  Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative.

Authors:  J C van Gemert; M C Berenbaum; G H Gijsbers
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.